CLINICAL_TRIALS
trial_result
· 2023-06-29
Clinical Trial Update: A Phase 2b Study to Evaluate RIST4721 in Palmoplantar Pustulosis (PPP) [Phase 2]
Summary
Phase 2b trial of RIST4721 in palmoplantar pustulosis was terminated; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Aristea Therapeutics, Inc. | Conditions: Palmoplantar Pustulosis | Phase 2 | Status: TERMINATED | Results posted: 2023-06-29